TY - JOUR
T1 - Differential roles of phospholipase D proteins in FcεRI-mediated signaling and mast cell function
AU - Zhu, Minghua
AU - Zou, Jianwei
AU - Li, Tieshi
AU - O'Brien, Sarah A.
AU - Zhang, Yao
AU - Ogden, Sarah
AU - Zhang, Weiguo
N1 - Publisher Copyright:
Copyright © 2015 by The American Association of Immunologists, Inc.
PY - 2015/11
Y1 - 2015/11
N2 - Phospholipase D (PLD) proteins are enzymes that catalyze the hydrolysis of phosphatidylcholine to generate an important signaling lipid, phosphatidic acid. Phosphatidic acid is a putative second messenger implicated in the regulation of vesicular trafficking and cytoskeletal reorganization. Previous studies using inhibitors and overexpression of PLD proteins indicate that PLD1 and PLD2 play positive roles in FcεRI-mediated signaling and mast cell function. We used mice deficient in PLD1, PLD2, or both to study the function of these enzymes in mast cells. In contrast to published studies, we found that PLD1 deficiency impaired FcεRI-mediated mast cell degranulation; however, PLD2 deficiency enhanced it. Biochemical analysis showed that PLD deficiency affected activation of the PI3K pathway and RhoA. Furthermore, our data indicated that, although PLD1 deficiency impaired F-actin disassembly, PLD2 deficiency enhanced microtubule formation. Together, our results suggested that PLD1 and PLD2, two proteins that catalyze the same enzymatic reaction, regulate different steps in mast cell degranulation.
AB - Phospholipase D (PLD) proteins are enzymes that catalyze the hydrolysis of phosphatidylcholine to generate an important signaling lipid, phosphatidic acid. Phosphatidic acid is a putative second messenger implicated in the regulation of vesicular trafficking and cytoskeletal reorganization. Previous studies using inhibitors and overexpression of PLD proteins indicate that PLD1 and PLD2 play positive roles in FcεRI-mediated signaling and mast cell function. We used mice deficient in PLD1, PLD2, or both to study the function of these enzymes in mast cells. In contrast to published studies, we found that PLD1 deficiency impaired FcεRI-mediated mast cell degranulation; however, PLD2 deficiency enhanced it. Biochemical analysis showed that PLD deficiency affected activation of the PI3K pathway and RhoA. Furthermore, our data indicated that, although PLD1 deficiency impaired F-actin disassembly, PLD2 deficiency enhanced microtubule formation. Together, our results suggested that PLD1 and PLD2, two proteins that catalyze the same enzymatic reaction, regulate different steps in mast cell degranulation.
UR - http://www.scopus.com/inward/record.url?scp=84945157609&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84945157609&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1500665
DO - 10.4049/jimmunol.1500665
M3 - Article
C2 - 26392467
AN - SCOPUS:84945157609
SN - 0022-1767
VL - 195
SP - 4492
EP - 4502
JO - Journal of Immunology
JF - Journal of Immunology
IS - 9
ER -